Search Results - "I. D. Safronov"

Refine Results
  1. 1

    Prooxidant-Antioxidant Factors in the Blood of Pregnant Women with Late Gestosis of Different Severity by Safronov, I. D, Trunov, A. N, Kokareva, E. D

    “…Prooxidant-antioxidant factors were studied in the blood of pregnant women with gestosis of different severity. Comparative study showed that activation of…”
    Get full text
    Journal Article
  2. 2

    Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure by Tepliakov, A T, Shilov, S N, Berezikova, E N, Efremov, A V, Safronov, I D, Pustovetova, M G, Maianskaia, S D, Torim, Iu Iu, Karpov, R S

    Published in Terapevtic̆eskii arhiv (2013)
    “…To study the impact of angiotensinogen (AGT) and angiotensin II receptor type 1 (AGTR1) gene polymorphisms on the development and course of chronic heart…”
    Get full text
    Journal Article
  3. 3

    The possibilities of treatment of recurrent colorectal cancer with sacral invasion by Musaev, E R, Polynovsky, A V, Rasulov, A O, Tsaryuk, V F, Kuz'michev, D V, Sushentsov, E A, Balyasnikova, S S, Safronov, D I

    Published in Hirurgija (Moskva) (2017)
    “…To describe current methods of surgical treatment of rare form of recurrent rectal cancer with sacral invasion. The article presents the methodology for the…”
    Get more information
    Journal Article
  4. 4

    Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure by A T Teplyakov, E N Berezikova, S N Shilov, E V Grakova, Yu Yu Torim, A V Efremov, I D Safronov, M G Pustovetova, R S Karpov

    Published in Terapevtic̆eskii arhiv (01-01-2015)
    “…Aim. To study the impact of a polymorphic variant of the matrix metalloproteinase-3 (MMP-3) gene on the development and course of chronic heart failure (CHF)…”
    Get full text
    Journal Article
  5. 5

    Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment by Tepliakov, A T, Shilov, S N, Berezikova, E N, Efremov, A V, Safronov, I D, Pustovetova, M G, Maianskaia, S D, Torim, Iu Iu, Karpov, R S

    Published in Kardiologiia (2013)
    “…Aim of investigation - to study effect of angiotensin-converting enzyme (ACE) gene polymorphism as a dominant risk factor of development of chronic heart…”
    Get more information
    Journal Article
  6. 6

    Characteristics of systemic inflammatory reaction in elderly patients of different age with the chronic heart failure by Efremov, A V, Maianskaia, S D, Safronov, I D, Pustovetova, M G, Berezikova, E N, Shilov, S N

    “…The peculiarities of development systemic inflammatory reactions during the chronic heart failure were studied in the research. The patients with different…”
    Get more information
    Journal Article
  7. 7

    Impact of Exogenous Proteolytic Enzymes on Immunogenesis in Patients with Urogenital Infections by A. A. Khryanin, O. V. Reshetnikov, I. D. Safronov

    “…The use of systemic enzyme therapy in combination with antibiotics in the treatment of urogenital chlamydia infection in patients of both sexes proved to…”
    Get full text
    Journal Article
  8. 8

    Localization of matrix metalloproteinases in the placenta of cows with complicated pregnancy by placental insufficiency by Avdeenko, V.S., Safronov, D.I., Akhmadov, V.T.

    Published in BIO web of conferences (01-01-2024)
    “…The placenta of 8 cows with physiological (PP) and placental insufficiency pregnancy (FPI) served as the material for the study. Analysis of the content of…”
    Get full text
    Journal Article
  9. 9

    EFFICACY OF AZITHROMYCIN AND ITS IMPACT IN CYTOKINE SYSTEM IN UROGENITAL INFECTIONS by A. A. Khryanin, O. V. Reshetnikov, I. D. Safronov, A. N. Trunov, N. B. Kulikova

    “…Seventy five patients with urogenital chlamydial and mycoplasmic infections were enrolled in the trial. In the etiotropic therapy azithromycin was used in the…”
    Get full text
    Journal Article
  10. 10

    STATE OF HUMORAL IMMUNITY IN WOMEN WITH NEOPLASTIC DISEASES OF THE UTERUS by A. V. Efremov, N. A. Matveevskij, A. N. Trunov, I. D. Safronov

    “…The purpose of this study was to examine changes in indicators that reflect the activation of the humoral immune system, the severity of the destructive…”
    Get full text
    Journal Article
  11. 11

    Condition of the humoral link of immune system at patients with endometrial cancer by A. V. Efremov, N. A. Matveevskij, A. N. Trunov, I. D. Safronov

    Published in Opukholi zhenskoĭ reproduktivnoĭ sistemy (01-08-2014)
    “…Examine changes in the parameters reflecting the activation of humoral immune system, the severity of the destructive processesand autoimmune reactions in…”
    Get full text
    Journal Article
  12. 12

    Impact of exogenous proteolytic enzymes on immunogenesis in patients with urogenital infections by Khrianin, A A, Reshetnikov, O V, Safronov, I D

    “…The use of systemic enzyme therapy in combination with antibiotics in the treatment of urogenital chlamydia infection in patients of both sexes proved to…”
    Get more information
    Journal Article
  13. 13

    Effects of caspase 8 gene polymorphism on the risks for development/course of chronic heart failure by Berezikova, Ye. N., Pustovetova, M. G., Shilov, S. N., Yefremov, A. V., Teplyakov, A. T., Safronov, I. D., Samsonova, Ye. N.

    “…The aim of the study was to identify genetic determinants of increased risks for heart failure severity. Clinical and genetic aspects of the effects of gene…”
    Get full text
    Journal Article
  14. 14

    ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ by Ye. N. Berezikova, M. G. Pustovetova, S. N. Shilov, A. V. Yefremov, I. D. Safronov, Ye. N. Samsonova, A. T. Teplyakov, Yu. Yu. Torim, R. Ye. Tuleutaeva

    “…Оценена взаимосвязь уровня растворимого Fas-лиганда (sFas-L) в сыворотке крови с тяжестью и характером течения хронической сердечной недостаточности (ХСН) у…”
    Get full text
    Journal Article
  15. 15

    Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure by Teplyakov, A T, Berezikova, E N, Shilov, S N, Grakova, E V, Torim, Yu Yu, Efremov, A V, Safronov, I D, Pustovetova, M G, Karpov, R S

    Published in Terapevtic̆eskii arhiv (2015)
    “…To study the impact of a polymorphic variant of the matrix metalloproteinase-3 (MMP-3) gene on the development and course of chronic heart failure (CHF) in…”
    Get more information
    Journal Article
  16. 16

    Efficacy of azithromycin and its impact on cytokine system in urogenital infections by Khrianin, A A, Reshetnikov, O V, Safronov, I D, Trunov, A N, Kulikova, N B

    “…Seventy five patients with urogenital chlamydial and mycoplasmic infections were enrolled in the trial. In the etiotropic therapy azithromycin was used in the…”
    Get more information
    Journal Article
  17. 17

    Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure by Berezikova, Ye. N., Pustovetova, M. G., Shilov, S. N., Yefremov, A. V., Teplyakov, A. T., Safronov, I. D., Samsonova, Ye. N.

    “…The aim of the study was to assess the relationship of homocysteine levels in the blood serum with the severity and nature of chronic heart failure (CHF) in…”
    Get full text
    Journal Article
  18. 18

    Influence of tocopherol on temperature of upper limbs at local cooling by Kulikov VYu, Kim, L B, Safronov, I D

    Published in Arctic medical research (01-01-1994)
    “…The influence of tocopherol (300 mg/day for 7 days) on skin temperature, arterial blood pressure and pulse rate at local cooling of upper limbs (submersion of…”
    Get more information
    Journal Article
  19. 19

    ЦИТОКИНОВЫЙ ПРОФИЛЬ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ by Ye. N. Berezikova, M. G. Pustovetova, S. N. Shilov, A. V. Yefremov, I. D. Safronov, Ye. N. Samsonova, A. T. Teplyakov, Yu. Yu. Torim

    “…Оценена взаимосвязь цитокинов интерлейкина-1 и рецепторного антагониста интерлейкина-1 с тяжестью и характером течения хронической сердечной недостаточности у…”
    Get full text
    Journal Article
  20. 20